-SEC Filing
JD.com Stock Is Down Tuesday – What’s Going On
JD.Com, Inc (NASDAQ: JD) stock traded lower Tuesday amid reports of its longer-term vision for
Related Posts
Apellis Shares Climb As FDA Accepts Geographic Atrophy Candidate Submission Under Priority Review
The U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review designation for Apellis Pharmaceuticals’ (NASDAQ: APLS) New Drug Application (NDA) for the intravitreal pegcetacoplan.
The regulatory agency has assigned target action date of November 26, 2022.
Don’t Lose Your Data: A Guide To Prevent Your Google Account From Being Deleted
If you want to prevent your Google account from being deleted, ensure you do at least one of the following activities.
Supreme Court Rules In Favor Of Apple For Now: What’s Going On?
Apple Inc (NASDAQ: AAPL) is facing selling pressure on Wednesday alongside the broader market, but the stock is getting a boost in afternoon trading after the U.S.